{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/guide-successful-planning-and-execution#webpage",
"url": "https://www.fortrea.com/insights/guide-successful-planning-and-execution",
"name": "A guide to successful planning and execution",
"description": "This Fortrea white paper explores clinical trial planning and execution strategies affecting operational performance and study delivery across clinical development programs. The content focuses on clinical trial planning and execution, operational strategy, study coordination, trial execution efficiency, risk mitigation approaches, and clinical development planning associated with clinical research programs. The white paper highlights factors related to workflow optimization, protocol execution, operational flexibility, study management, and coordination approaches affecting clinical trial timelines and performance. Fortrea discusses operational and strategic perspectives designed to support efficient clinical trial execution, strengthen planning approaches, and improve coordination across clinical development activities. By integrating operational strategy with execution efficiency and risk mitigation planning, the white paper provides insights into clinical trial planning and execution across evolving clinical research environments."
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "A guide to successful planning and execution",
"item": "https://www.fortrea.com/insights/guide-successful-planning-and-execution"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry—as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. This commitment is further reinforced by the launch of Fortrea Intelligent Technology, enabling smarter, more connected, and data-driven clinical development. Through Fortrea Intelligent Technology, the organization is advancing data-driven, technology-enabled clinical development to improve speed, quality, and patient outcomes. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/guide-successful-planning-and-execution#whitepaper",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/guide-successful-planning-and-execution#webpage"
},
"headline": "Early-Phase Clinical Trial Planning & Execution Strategies | Fortrea White Paper",
"description": "This Fortrea white paper explores clinical trial planning and execution strategies affecting operational performance and study delivery across clinical development programs. The content focuses on clinical trial planning and execution, operational strategy, study coordination, trial execution efficiency, risk mitigation approaches, and clinical development planning associated with clinical research programs. The white paper highlights factors related to workflow optimization, protocol execution, operational flexibility, study management, and coordination approaches affecting clinical trial timelines and performance. Fortrea discusses operational and strategic perspectives designed to support efficient clinical trial execution, strengthen planning approaches, and improve coordination across clinical development activities. By integrating operational strategy with execution efficiency and risk mitigation planning, the white paper provides insights into clinical trial planning and execution across evolving clinical research environments.",
"genre": "White Paper",
"image": {
"@type": "ImageObject",
"url": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png"
},
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2025-11-26",
"dateModified": "2025-11-26",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2025-11/guide-to-successful-planning-and-execution.pdf",
"encodingFormat": "application/pdf"
}
}
]
}